Purchase Order 75N91024P00385

Award Date 6/20/24
Potential Completion Date 6/19/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $21,394.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the maintenance of an IncuCyte SX5 live cell imaging system used for real-time cell health and viability measurements to support biomedical research. The award has an ultimate completion date of April 30, 2026 and was not set aside for any specific business type....
This $15,656.00 firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for a service agreement with a period of performance through September 9, 2025. Sartorius Corporation, which is primarily a supplier of advanced biomedical instruments, consumables, software, and associated...
This is a $15,972.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract is for a service agreement to provide the NCI with an IncuCyte S3 Live Cell Analysis System, which is a specialized biomedical instrument used for cutting-edge research in areas such as infectious diseases,...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,969.40 contract is for a service agreement to provide the NCI with the S3 IncuCyte live-cell analysis system, which supports cutting-edge biomedical research across infectious diseases, cancer studies, and translational sciences....
This is a federal contract award to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract, awarded by the National Cancer Institute (a component of the National Institutes of Health), is for a maintenance agreement valued at $20,767.00. The contract has a firm fixed price and an ultimate completion date of October 31, 2025. Sartorius Corporation has established itself as a trusted...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the provision of an IncuCyte S3 live-cell analysis system and associated software and services from December 1, 2024 to November 30, 2025 at a ceiling value of $15,656.00. The contract was awarded on...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The $20,590 contract is for a maintenance agreement for an Octet R4 instrument, which is a live-cell analysis system used in biomedical research and development. The contract has a period of performance through November 3, 2025. Sartorius...
This is a one-year service contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract, valued at $15,969.52, is for the maintenance and servicing of a Sartorius Incucyte* live-cell analysis system, serial number IC51523, during the period from March 1, 2025, to February 28, 2026. The contract is a firm-fixed-price...
This firm-fixed-price purchase order for $15,904.85 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and biotech solutions. The contract provides for preventative maintenance services on Sartorius' proprietary IncuCyte S3 live-cell analysis systems over a period ending on December 20, 2025. As a key supplier...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract, valued at $13,810.00, is for a maintenance agreement with an ultimate completion date of February 28, 2026. Sartorius Corporation, a key supplier to various government agencies including the NCI, NIH,...

This is a firm fixed-price purchase order awarded by the National Cancer Institute to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $20,767.00 contract is for an Incucyte SX5 Preventive Service Plan, a specialized biomedical instrument and associated maintenance services. Sartorius has a history of providing the National Institutes of Health, Food and Drug Administration, and other Department of Health and Human Services agencies with a range of laboratory tools, consumables, and technical support for biomedical and translational research programs. While most of Sartorius' federal contracts have been competitively awarded without set-asides, the company has occasionally partnered with larger subcontractors to fulfill government requirements. This award does not indicate the use of any small business set-aside program.

Generated 6/28/24, 9:04 AM